Antifibrotic therapy and its indications for interstitial pulmonary fibrosis.
Vnitr Lek
; 68(4): 212-215, 2022.
Article
in En
| MEDLINE
| ID: mdl-36220417
ABSTRACT
Idiopathic pulmonary fibrosis and chronic fibrotic interstitial lung disease with progressive phenotype are characterized by fibrotic lung parenchyma. Current antifibrotic treatment does not affect pre-existing lung parenchyma fibrosis, but prevents fibrosis progression and reduces mortality by reducing fibrotization. This work summarizes fibrotic lung processes and their treatment options.
Key words
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lung Diseases, Interstitial
/
Idiopathic Pulmonary Fibrosis
Limits:
Humans
Language:
En
Journal:
Vnitr Lek
Year:
2022
Type:
Article